Literature DB >> 11489088

Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic-pituitary-adrenal axis activity in rats.

V Grinevich1, X M Ma, J P Herman, D Jezova, I Akmayev, G Aguilera.   

Abstract

The effects of chronic immune challenge on cytokine expression and hypothalamic-pituitary-adrenal axis (HPA) axis responses to stress were studied in Wistar rats after administration of increasing doses of lipopolysaccharide (LPS). Repeated LPS (R-LPS) decreased body weight and increased adrenal weight and pituitary pro-opiomelanocortin mRNA levels. LPS injection increased plasma adrenocorticotropic hormone (ACTH) and corticosterone but the effect was attenuated in R-LPS. Plasma corticosterone but not ACTH responses to restraint were also reduced in R-LPS. Basal and restraint-stimulated corticotropin releasing hormone (CRH) mRNA levels were lower in R-LPS, but responses to a new LPS injection were similar to controls. In contrast, type 1 CRH receptor (CRH-R1) mRNA responses to both LPS and restraint were blunted in R-LPS. Vasopressin mRNA levels in parvocellular neurones were higher in R-LPS, and increased further after restraint but not after a new LPS injection. Glucocorticoid receptor (GR) levels in the paraventricular nucleus (PVN) increased after a single LPS or R-LPS (24 h after the last injection) but declined after a new injection in R-LPS. Interleukin (IL)-1beta and IL-6 mRNAs increased in the pituitary, spleen and circumventricular organs after single or R-LPS, suggesting that cytokines may contribute to the activation of the HPA axis though pathways from the circumventricular organs as well as paracrine effects in the pituitary. The data show that (i) adaptation of the HPA axis during repeated LPS injection involves increases in vasopressin : CRH expression ratios in parvocellular neurones; (ii) that hypothalamic CRH and vasopressin responses to acute stimulation are independent of CRH-R1 expression in the PVN; and (iii) there is a dissociation between pituitary and adrenal responses to acute stress suggesting a decrease of adrenal sensitivity to ACTH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489088     DOI: 10.1046/j.1365-2826.2001.00684.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  19 in total

1.  Hematological parameters in wistar rats in conditions of stress and treatment with heparin.

Authors:  M V Kondashevskaya; V A Mkhitarov
Journal:  Neurosci Behav Physiol       Date:  2006-01

Review 2.  Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Authors:  Robert K McNamara; Francis E Lotrich
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

3.  Fluorescent Arc/Arg3.1 indicator mice: a versatile tool to study brain activity changes in vitro and in vivo.

Authors:  Valery Grinevich; Alexander Kolleker; Marina Eliava; Naoki Takada; Hiroshi Takuma; Yugo Fukazawa; Ryuichi Shigemoto; Dietmar Kuhl; Jack Waters; Peter H Seeburg; Pavel Osten
Journal:  J Neurosci Methods       Date:  2009-07-21       Impact factor: 2.390

4.  In vivo Angiotensin II AT1 receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland.

Authors:  Enrique Sánchez-Lemus; Julius Benicky; Jaroslav Pavel; Juan M Saavedra
Journal:  Brain Behav Immun       Date:  2009-05-07       Impact factor: 7.217

5.  Mitigation of Inflammation-Induced Mood Dysregulation by Long-Chain Omega-3 Fatty Acids.

Authors:  Robert K McNamara
Journal:  J Am Coll Nutr       Date:  2015       Impact factor: 3.169

6.  New insights into cytokine gene expression in the rat hypothalamus following endotoxin challenge.

Authors:  David S Jessop; Hugo O Besedovsky; Adriana del Rey
Journal:  Neurochem Res       Date:  2009-10-09       Impact factor: 3.996

7.  Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior.

Authors:  George R Breese; Darin J Knapp; David H Overstreet; Montserrat Navarro; Tiffany A Wills; Robert A Angel
Journal:  Neuropsychopharmacology       Date:  2007-06-06       Impact factor: 7.853

8.  Vasopressin does not mediate hypersensitivity of the hypothalamic pituitary adrenal axis during chronic stress.

Authors:  Jun Chen; Sharla Young; Sivan Subburaju; Jack Sheppard; Alexander Kiss; Helen Atkinson; Susan Wood; Stafford Lightman; Claudine Serradeil-Le Gal; Greti Aguilera
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

9.  Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness.

Authors:  Skylar Kelsven; Camilo de la Fuente-Sandoval; Cristian L Achim; Francisco Reyes-Madrigal; Heline Mirzakhanian; Isabel Domingues; Kristin Cadenhead
Journal:  Schizophr Res       Date:  2020-02-20       Impact factor: 4.939

10.  Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland.

Authors:  Enrique Sanchez-Lemus; Yuki Murakami; Ignacio M Larrayoz-Roldan; Armen J Moughamian; Jaroslav Pavel; Tsuyoshi Nishioku; Juan M Saavedra
Journal:  Endocrinology       Date:  2008-06-12       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.